MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study

    S. Isaacson, N. Giladi, F. Stocchi, L. Salin, N. Vostokova, W. Poewe (Boca Raton, USA)

    Objective: To report long-term safety and tolerability data from the ongoing BeyoND study (NCT02726386) for patients who continued treatment past the one-year primary endpoint. Background:…
  • 2022 International Congress

    Plasma p-Tau181 and p-Tau231 in Parkinson’s Disease

    MC. Gonzalez, NJ. Ashton, A. Pilitto, A. Padovani, B. Fernandes Gomes, DA. Tovar-Rios, F. Blanc, A. Lemstra, C. Paquet, C. Abdelnour, M. Boada, L. Bonanni, R. Vandenberghe, K. Blennow, H. Zetterberg, D. Aarsland (Stavanger, Norway)

    Objective: To explore whether plasma phosphorylated tau (p-Tau) 181 and p-Tau231 levels are associated with cognition in a Parkinson’s Disease (PD) cohort. Background: We recently…
  • 2022 International Congress

    A facilitated self-management toolkit for people with Parkinson’s disease: A feasibility study of ‘Live Well with Parkinson’s

    M. Armstrong, T. Rookes, A. Schrag, K. Walters (London, United Kingdom)

    Objective: To assess the feasibility and acceptability of a theory and evidence-based digital facilitated self-management toolkit for people with Parkinson’s: ‘Live Well with Parkinson’s’. Background:…
  • 2022 International Congress

    Inflammatory microglial and astroglial phenotype associated with pathological alpha-synuclein inclusions in the substantia nigra

    A. Stoll, M. Bensky, J. Patterson, C. Kemp, K. Steece-Collier, M. Hore, K. Luk, C. Sortwell (Grand Rapids, USA)

    Objective: To characterize neuroinflammatory gene expression in microglia and astrocytes associated with early alpha-synuclein (a-syn) inclusion formation. Background: Parkinson’s disease (PD) is characterized by alpha-synuclein…
  • 2022 International Congress

    Isolated craniocervical dystonia without neuropsychiatric manifestations associated with NMDA-receptor antibodies

    S. Waller, L. Williams, A. Lee, MW. Lin, H. Morales-Briceno, V. Fung (Westmead, Australia)

    Objective: N-methyl-D-aspartate receptor (NMDAR) encephalitis classically spans neuropsychiatric disturbance, autonomic dysfunction and salient movement disorders. Attenuated presentations are increasingly recognised; however, presentations with an isolated…
  • 2022 International Congress

    Alterations in neuron-derived exosomal cargo in Parkinson Disease

    V. Gorgogietas, IB. Boussaad, F. Borgmann, M. Mittelbronn, R. Krueger (Esch-sur-Alzette, Luxembourg)

    Objective: The main objectives are 1) the confirmation of exosome isolation, based on iPSC-derived midbrain neuron model, 2) the identification of α-synuclein cargo of PD-patient…
  • 2022 International Congress

    Effects of directional subthalamic deep brain stimulation on gait and balance in Parkinson Disease patients.

    S. Cherif, C. Olivier, J. Bourilhon, D. Bannier, D. Maltête, B. Lau, S. Derrey, E. Bardinet, C. Karachi, M. Welter (Paris, France)

    Objective: To assess the effects of directional STN-DBS on gait and balance in PD patients Background: STN-DBS is efficient to treat motor signs in PD…
  • 2022 International Congress

    The effects of on-demand auditory cueing on home-based freezing of gait in people with Parkinson’s disease

    D. Zoetewei, T. Herman, L. Palmerini, A. Ferrari, J. Hausdorff, A. Nieuwboer, P. Ginis (Leuven, Belgium)

    Objective: To evaluate the effects of on-demand auditory cueing on video-rated freezing of gait (FOG) during home-based FOG-provoking tests in people with Parkinson’s disease. Background:…
  • 2022 International Congress

    Influence of dopaminergig medication and subthalamic nucleus deep brain stimulation on impulsive decision making in Parkinson’s disease

    JC. Baldermann, A. Nehs, H. Jergas, H. Dafsari, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate how impulsive decision making is modulated by regular dopaminergic medication and by switching between active contacts of subthalamic nucleus stimulation Background: Impulsive…
  • 2022 International Congress

    Exploring the diversity of alleviating manoeuvres in Cervical Dystonia

    L. Avanzino, F. Di Biasio, G. Bonassi, E. Pelosin, N. Cothros, R. Marchese, D. Martino (Genoa, Italy)

    Objective: We explored five different categories of alleviating manoeuvres (AMs) in patients with cervical dystonia (CD): pure sensory; sensorimotor manoeuvres in which sensory input is…
  • « Previous Page
  • 1
  • …
  • 611
  • 612
  • 613
  • 614
  • 615
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley